Guillain-Barré syndrome following pandemic (H1N1) 2009 influenza A immunisation in Victoria: A self-controlled case series

Medical Journal of Australia

Volumn 197, Issue 10, 2012, Pages 574-578

  Crawford, Nigel W ^a   Cheng, Allen ^b   Andrews, Nick ^c   Charles, Patrick G ^d   Clothier, Hazel J ^e   Day, Bruce ^b   Day, Timothy ^e   Gates, Peter ^f   Macdonell, Richard ^d   Roberts, Les ^g   Rodriguez Casero, Victoria ^a   Wijeratne, Tissa ^h   Kiers, Lynette ^e  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b ALFRED HOSPITAL   (Australia)

^c PUBLIC HEALTH ENGLAND   (United Kingdom)

^d AUSTIN HEALTH   (Australia)

^e ROYAL MELBOURNE HOSPITAL   (Australia)

^f BARWON HEALTH   (Australia)

^g ST VINCENT S HOSPITAL   (Australia)

^h WESTERN HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

2009 H1N1 INFLUENZA; ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL OUTCOME; DISEASE SURVEILLANCE; DRUG SAFETY; FEMALE; GUILLAIN BARRE SYNDROME; HUMAN; INCIDENCE; INFLUENZA VACCINATION; INTERVIEW; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; VICTORIA; AUSTRALIA; HEALTH SURVEY; INFLUENZA; INFLUENZA VIRUS A H1N1; METHODOLOGY; MIDDLE AGED; PANDEMIC; RISK; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; FEMALE; GUILLAIN-BARRE SYNDROME; HUMANS; INCIDENCE; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; PANDEMICS; POPULATION SURVEILLANCE; RESEARCH DESIGN; RISK; VICTORIA; YOUNG ADULT;

EID: 84879758167     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/mja12.10534     Document Type: Article

References (26)

1. Greenberg ME, Lai MH, Hartel GF, et al. Response to a monovalent influenza A (H1N1) vaccine. N Engl J Med 2009; 361: 2405-2413.
2. Sejvar JJ, Kohl KS, Gidudu J, et al. Guillain-Barré syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine 2011; 29: 599-612.
3. Schonberger LB, Bergman DJ, Sullivan-Bolyai JZ, et al. Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976-1977. Am J Epidemiol 1979; 110: 105-123.
4. Hughes RA, Charlton J, Latinovic R, Gulliford MC. No association between immunization and Guillain-Barré syndrome in the United Kingdom, 1992 to 2000. Arch Intern Med 2006; 166: 1301-1304.
5. Stowe J, Andrews N, Wise L, Miller E. Investigation of the temporal association of Guillain-Barre syndrome with influenza vaccine and influenzalike illness using the United Kingdom General Practice Research Database. Am J Epidemiol 2009; 169: 382-388.
6. Juurlink DN, Stukel TA, Kwong J, et al. Guillain-Barré syndrome after influenza vaccination in adults: a population-based study. Arch Intern Med 2006; 166: 2217-2221.
7. Sivadon-Tardy V, Orlikowski D, Porcher R, et al. Guillain-Barré syndrome and influenza virus infection. Clin Infect Dis 2009; 48: 48-56.
8. Haber P, Sejvar J, Mikaeloff Y, DeStefano F. Vaccines and Guillain-Barré syndrome. Drug Saf 2009; 32: 309-323.
9. Andrews N, Miller E, Waight P, et al. Does oral polio vaccine cause intussusception in infants? Evidence from a sequence of three selfcontrolled cases series studies in the United Kingdom. Eur J Epidemiol 2001; 17: 701-706.
10. Stowe J, Kafatos G, Andrews N, Miller E. Idiopathic thrombocytopenic purpura and the second dose of MMR. Arch Dis Child 2008; 93: 182-183.
11. Farrington CP, Nash J, Miller E. Case series analysis of adverse reactions to vaccines: a comparative evaluation. Am J Epidemiol 1996; 143: 1165-1173.
12. Whitaker HJ, Hocine MN, Farrington CP. The methodology of self-controlled case series studies. Stat Methods Med Res 2009; 18: 7-26.
13. Lasky T, Terracciano GJ, Magder L, et al. The Guillain-Barré syndrome and the 1992-1993 and 1993-1994 influenza vaccines. N Engl J Med 1998; 339: 1797-1802.
14. Farrington CP, Whitaker HJ, Hocine MN. Case series analysis for censored, perturbed, or curtailed post-event exposures. Biostatistics 2009; 10: 3-16.
15. Musonda P, Farrington CP, Whitaker HJ. Sample sizes for self-controlled case series studies. Stat Med 2006; 25: 2618-2631.
16. Australian Bureau of Statistics. State and regional indicators, Victoria, June 2010. (ABS Cat. No. 1367.2.) http://www.abs.gov.au/AUSSTATS/abs@.nsf/DetailsPage/1367.2Jun+2010 (accessed May 2011).
17. Greene SK, Rett M, Weintraub ES, et al. Risk of confirmed Guillain-Barre syndrome following receipt of monovalent inactivated influenza A (H1N1) and seasonal influenza vaccines in the Vaccine Safety Datalink Project, 2009-2010. Am J Epidemiol 2012; 175: 1100-1109.
18. Wise ME, Viray M, Sejvar JJ, et al. Guillain-Barre syndrome during the 2009-2010 H1N1 influenza vaccination campaign: population-based surveillance among 45 million Americans. Am J Epidemiol 2012; 175: 1110-1119.
19. Yih WK, Lee GM, Lieu TA, et al. Surveillance for adverse events following receipt of pandemic 2009 H1N1 vaccine in the Post-Licensure Rapid Immunization Safety Monitoring (PRISM) System, 2009-2010. Am J Epidemiol 2012; 175: 1120-1128.
20. Dieleman J, Romio S, Johansen K, et al; VAESCOGBS Case-Control Study Group. Guillain-Barrre syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine: multinational case-control study in Europe. BMJ 2011; 343: d3908.
21. Andrews N, Stowe J, Al-Shahi Salman R, Miller E. Guillain-Barré syndrome and H1N1 (2009) pandemic influenza vaccination using an AS03 adjuvanted vaccine in the United Kingdom: selfcontrolled case series. Vaccine 2011; 29: 7878-7882.
22. Liang X-F, Li L, Liu DW, et al. Safety of influenza A (H1N1) vaccine in postmarketing surveillance in China. N Engl J Med 2011; 364: 638-647.
23. Choe YJ, Cho H, Bae GR, Lee JK. Guillain-Barré syndrome following receipt of influenza A (H1N1) 2009 monovalent vaccine in Korea with an emphasis on Brighton Collaboration case definition. Vaccine 2011; 29: 2066-2070.
24. Australian Institute of Health and Welfare. 2010 Pandemic Vaccination Survey: summary results. Canberra: AIHW, 2010. (AIHW Cat. No. PHE 128.) http://www.aihw.gov.au/publication-detail/?id=6442468387 (accessed Jan 2012).
25. Hicks SC, James RE, Wong N, et al; Australasian Gastro-Intestinal Trials Group. A case study evaluation of ethics review systems for multicentre clinical trials. Med J Aust 2009; 191: 280-282.
26. Dodd CN, Romio SA, Izurieta H, et al. International collaborative case series safety monitoring for pandemic 2009 H1N1 vaccines: estimation of the risk of Guillain-Barré syndrome [abstract]. Proceedings of the 28th International Conference on Pharmacoepidemiology and Therapeutic Risk Management; 2012 Aug 23-26; Barcelona, Spain.